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Abstract
There has been unprecedented development in tissue engineering (TE) over the last few years
owing to its potential applications, particularly in bone reconstruction or regeneration. In this
article, we illustrate several advantages and disadvantages of different approaches to the
design of electrospun TE scaffolds. We also review the major benefits of electrospun fibers for
three-dimensional scaffolds in hard connective TE applications and identify the key strategies
that can improve the mechanical properties of scaffolds for bone TE applications. A few
interesting results of recent investigations have been explained for future trends in TE scaffold
research.
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1. Introduction
There has been enormous progress in tissue engineering
(TE) in recent years. TE scaffolding materials have been
extensively explored for the regeneration of various parts of
the human body, including skin [1], muscle [2], teeth [3],
bone [4,5], cartilage [4], ligament [6], spinal cord [7],
nerve [8], genome [9] and artificial organs, particularly
cardiac tissues or heart [10], lung [11], kidney [12], liver [13],
urinary bladder [14], blood vessels [15], stomach [16],
intestine [17], breast [18], ear [19], eye [20] and nose [21].
TE includes the combined growth of living cells, tissues or
organs, as well as methods and materials that can restrain
the shape of a particular tissue for better functions. When a
group of cells (e.g. osteoblasts, osteocytes, osteoclasts and
osteoprogenitor cells) perform the same function together,
they are called tissue (e.g. bone tissue), which can relate
to different organs. The essential human organs, including
bone, with different engineering key factors of scaffolds for
corresponding functional systems are illustrated in figure 1.
In the skeletal system, the extracellular matrix becomes
calcified in bone tissue unlike other connective tissues. The
hard tissue or bone provides an internal support to the
body via attached tendons and muscles and has several
metabolic functions, especially in calcium homeostasis. The
remodeling and reorganization of bone tissue have various
causes, including mechanical stimuli, metabolic causes (i.e.
lack of dietary calcium, illness and aging), endocrine changes
and effects of drugs. Over the past two decades, many
techniques have been developed to design suitable scaffolds
for repairing and regenerating various tissues. However, no
suitable scaffold has been designed or developed yet for
the repair or regeneration of bone tissue because of its
complex composition, peculiar structure and extraordinary
mechanical and biological properties. Therefore, in this
review, we aim to outline key strategies that can improve the
mechanical properties of scaffolds for bone TE applications.
We also focus on electrospun scaffolds made of nanofibers to
emphasize their benefits for bone tissue repair or regeneration.
1.1. Key engineering properties of primary tissues
The five main primary tissues, which are generally prepared
by electrospinning for implantation into the human body,
are epithelial, connective, fluid, nerve and muscles. The
basic desired properties of engineering scaffolds for different
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Figure 1. Schematic of essential human organs listing functionalities required from implanted scaffolds.
tissues and the effect of electrospun materials on the TE
scaffolds are illustrated in table 1.
Depending on the applications and functions, an
electrospun TE scaffold can be temporary or permanent.
Usually, a temporary scaffold is highly porous and fully
biodegradable, without side effects of by-products, whereas
a permanent scaffold is highly biocompatible, mechanically
strong, nondegradable, and remains inside the body for a long
time.
1.2. Different tissue engineering approaches
Depending on the source of scaffolds, raw materials
and applications, TE can be approached by using four
main types of material: premade porous scaffold [33],
decellularized extracellular matrix (ECM) [34], cell-sheets
with secreted ECM [35] and cell-encapsulated self-assembled
hydrogels [36] (see figure 2).
1.2.1. Premade porous scaffolding. In this approach, a
porous scaffold is produced from different synthetic raw
materials using various scaffold fabrication techniques. Then,
living cells are seeded on the porous scaffold, and the
resulting scaffold is implanted into the body for growing
host tissues. The main advantages of this approach are low
cost, availability of diverse raw materials, easy handling
and simple technique. However, this strategy results in
undesired responses from host tissues owing to the lack
of biocompatibility, tissue adherence, surface chemistry,
mechanochemical stability, and mismatch of degradation rate
kinetics with the formation of new tissue.
1.2.2. Decellularized ECM scaffolding. The decellularized
ECM technique is similar to the premade porous scaffolding;
only the source of the scaffold is different. Here, native
tissues are collected from decellularized ECM of similar
tissue from another part of the body. The ECM includes
the structural components of the niche such as soluble cue,
matrix cue, stem cells, basement membrane and niche cells.
It provides a physical platform for cell attachment, migration
and division. The ECM acts as a reservoir of growth factors
and potentiates their actions. It also sends biochemical signals
to the cells that are modulated via molecular interactions with
ECM biomolecules, such as heparin sulfate proteoglycans
(HSPGs), or through adjacent cells. Here, the decellularized
ECM exhibits several attractive characteristics as a TE
scaffold that favors the ECM tissues for long-term in vivo
applications. Some of the main advantages of this technique
over premade scaffolding are lower toxicity, cacogenicity
and bioincompatibility. However, this approach has failed
in many cases owing to the immunogenicity of the used
biomaterials and the cell necrosis at the bulk scaffold related
to oxygen deficiency and diffusion of nutrients. Another
demerit of this approach is that the donor tissue is likely to
elicit immunogenic responses and contain large variation over
different batches [37].
1.2.3. Cell-sheets with secreted ECM. In this method, the
confluent cells are collected from its own ECM secretion,
which is secreted from different glands or organs, to prepare
a cell-sheet layer. The secreted cells are harvested only
by cell culture (without using enzymatic treatment), on
a culture dish coated with a thermoresponsive polymer
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Table 1. Properties of TE scaffolds desired for different tissues and effects of electrospun materials on TE scaffolds.
Biological Key engineering Effect of electrospun materials on TE
Tissue description properties scaffolds Use of scaffolds
Epithelial tissue Joined together Very low elastic moduli Electrospun collagen nanofibers can
e.g. skin with same (0.1–0.2 MPa), optimum improve the structural integrity and
tissue; soft and pore size (20–125µm) mechanical strength of skin tissues. The
elastic [22] scaffolds made of electrospun nanofibers
provide a high surface area-to-volume
ratio, which promotes the cell–matrix
interaction at the nanoscale [23]
Skin wound healing
Connective tissue Joins different High tensile, Electrospun nanofibers with high surface
e.g. bone, tissues; strong compressive, and porosity improve cell ingrowth and the
tendon, ligament, and tough torsional strengths, high mechanical properties of the scaffold
cartilage and fat elastic moduli, optimum [26,27]





Fluid tissue Transports food, Specified viscosity, The high surface-to-volume ratio of the
e.g. blood, nutrients and surface tension, mass electrospun synthetic fibrinogen nanofibers
fibrinogen waste products; transport property and can improve the blood clotting process in
(natural polymer viscous pH wound healing after reacting with thrombin
present in blood by forming a network structure of a fibrous
plasma), thrombin compound called fibrin [28]
Blood plasma
modification
Nerve tissue Sensitive to Smart properties; high High aspect ratio of electrospun nanofibers
various stimuli ionic, electrical and enhances the conductivity of sensors via
thermal conductivities, electron transport, which is extremely






Voluntary muscle Made of striated Medium elastic Electrospun nanofibers of polyester urethane
tissue muscle fibers modulus and and poly(l-lactide-co-ε-
e.g. arm, leg and supported by high fatigue caprolactone) have satisfactory mechanical
skeletal muscles connective endurance under properties and encouraging cellular response
tissues and cyclic load in terms of adhesion and differentiation; they
stimulated by can be used in scaffolds for skeletal [30]
nerves or smooth [31] muscles
Artificial muscles
Involuntary Smooth and not Low elastic modulus Small intestinal submucosa (SIS) composed
muscle tissue human- and high fatigue of type-I and type-III collagens and various
e.g. intestines, controlled; soft endurance limit cytokines leads to superior initial cell
heart or cardiac under cyclic load attachment and proliferation compared with
muscles synthetic polymeric scaffolds in presence of
growth factors. Electrospun SIS/
poly(ε-caprolactone) hybrids have a
stable micro/nanofibrous structure, which
provide improved hydrophilicity,
mechanical properties and cellular behavior
to the scaffolds [32]
Artificial intestine
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Figure 2. Different TE regeneration techniques.
(e.g. poly(N-isopropylacrylamide)), until confluence. The
confluent cell-sheet is then isolated using thermally regulated
hydrophobic polymer coatings. Such approach can be
repeated to obtain a thicker matrix of multiple-cell-sheet
in a thermoresponsive culture dish by laminating a few
single-cell sheets. After that, the cell-sheets are recovered
from the dish using a low-temperature treatment. Finally,
the multiple-cell-sheets are transferred and implanted into
the body to observe the ingrowth properties of the host
tissues. In some cases, this method is more advantageous
than the decellularized ECM scaffolding due to the lower
immunogenicity of the biomaterials used to form new tissues.
1.2.4. Cell-encapsulated self-assembled hydrogel.
Cell-encapsulation is a method of entrapping living cells
within a homogenous solid mass or a semipermeable
membrane. The biomaterials used for encapsulation are
usually natural and synthetic hydrogels, which are made by
covalent or ionic crosslinking of water-soluble polymers.
Here, usually, one monomer solution of a completely
biodegradable polymer is prepared by a self-mixing technique
to make a cell-encapsulated hydrogel. The hydrogels can be
formed through several gelation mechanisms, where polymer
chains are crosslinked via covalent, ionic or physical bonds.
Finally, the encapsulated hydrogel material is injected into
the body to regenerate the host tissue. This technique is
generally used for tissue regeneration via drug delivery or for
soft tissue regeneration because of the high biodegradability
and reduced mechanical properties of the hydrogel. Recently,
this technique has also been tried for cartilage TE scaffolds
by increasing the mechanical fracture strength through
developing double networks in the hydrogel polymer chains.
Interestingly, it has been found that the toughness and strength
of the hydrogels are increased with void formation up to a
certain void size or optimum void fraction (e.g. 1–3 vol%
for polyacrylamide, PAAm). Below the critical size, the
polymer (i.e. PAAm) chains can bridge the void gap and
create additional stress on the void. Above the critical void
size, the chains are too small to bridge the gap and the void
can form a true hollow stress-free structure [38].
Over the past decades, many scaffold materials have
been tried for TE applications. However, no material was
fully suitable for long-term implantations of bone TE
scaffolds despite the specific advantages of each material.
The failure might have occurred owing to the lack of
consistency in material properties including mechanical
stability, biodegradability, biocompatibility, toxicity, thermal
or electrical sensitivity, permeability, surface adhesivity,
hydrophilicity or hydrophobicity and fluidity in terms of
viscosity. The consistency in material properties can be
improved by the proper selection of materials, design and
fabrication procedure. In this context, electrospun scaffolds
performed better than other scaffolds.
2. Basic criteria for design and development of TE
scaffolds
The essential criteria for designing and developing an ideal
three-dimensional (3D) TE scaffold are summarized in
table 2.
2.1. Scaffold design
Since the design of scaffold architecture is crucial for
improving its performance, the selection of a unit cell for
obtaining an ideal 3D scaffold must be included. The unit cell,
which is a building block of a 3D scaffold material, is similar
to a cell in a tissue. The different geometrical shapes of unit
cells such as cubic, diamond, gyroid [44], honeycomb [45]
and accordion-like honeycomb [46] provide different 3D
pores to scaffolds (figure 3). It has also been found that the
tissue growth depends on the geometrical shape of the unit
cells of 3D pores in a scaffold [47]. The shape of the unit cells
depends on the fabrication technique. For electrospun fibrous
scaffolds, the unit cell geometry of a 3D scaffold is defined
by the arrangement of fibers, which in turn controls the
interconnecting porosity in the scaffold [2, 37, 48]. However,
controlling the uniformity in 3D structure generation via
electrospinning is very difficult without a deep involvement of
the whole architecture of the scaffold, including the unit cell
geometry and fiber orientation. To better understand the basic
use of fibers in 3D TE scaffold development, different fiber
arrangements and the surface morphology of a regenerative
scaffold are illustrated in figure 4.
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Table 2. Criteria for designing electrospun fibers and TE scaffolds.
Function Design criteria
Strong, uniform and High-molecular-weight polymers
bead-free fibers having high ionic conductivity,
concentration, or viscosity; high operating
voltage in electrospinning process [39]
Thin fibers, needle-like Electrospinning at high voltages
tip design and low flow rates [40]
Aligned electrospun fibers High rotating target speed [40];
collector geometry
Structural stability to Maintaining mechanical properties throughout
retain tissue shape the 3D scaffold by strong electrospun nanofibers
Transport of nutrients and High porosity and interconnectivity between
waste in and out of the pores formed by maintaining preferred
electrospun scaffold orientation of fibers [41]
Degradation integrity of Balancing degradation and formation of tissue
electrospun scaffold to leave without toxic by-products [42]
host tissue
Elimination of inflammatory Materials must be biocompatible, nontoxic
response or toxicity from the and noncarcinogenic
electrospun scaffold
High cell seeding density and Large pore size, high porosity and high
cell migration leading to interconnectivity between pores using
tissue growth throughout the preferred unit cell geometry of the
scaffold electrospun scaffolds [43]
Better cell attachment and Optimized surface chemistry/topography
proliferation and high surface-to-volume ratio
New cell or ECM growth in Proper fiber orientation within
preferred direction the scaffold [22]
Growth of 3D tissues and Specific 3D shape of electrospun scaffolds
organs using preferred unit cell geometry [43]
Figure 3. Unit cells for 3D scaffolds: (a) cubic, (b) diamond, (c)
gyroid, (d) honeycomb and (e) accordion-like honeycomb.
2.2. Scaffold material development
Many scaffold materials have been exploited recently for
a wide range of TE applications. Among the three classes
of scaffolding materials, namely, ceramics, polymers and
composites only the last two can be easily electrospun into
nanofibers, as ceramic materials have not been electrospun
thus far without adding an organic functional material or
polymer. Table 3 presents a summary of attempts [49–53]
to fabricate porous 3D scaffolds for TE applications by
electrospinning.
In the previous decade, conventional techniques such as
solvent casting, particle leaching, salt fusion, gas foaming,
fused deposition modeling and so on were exploited for
TE applications. More recently, the rapid prototype (RP)
process, also known as solid free-form fabrication (SFF)
process, has achieved great success owing to its automatic
or semiautomatic rapid manufacturing procedures and the
ability to design any complex geometry layer by layer [53].
The most important RP techniques are stereolithography [50],
photopolymerizing, fused deposition modeling, selective
laser sintering, 3D printing and bioplotting. Although most
materials processed in commercial RP or SFF machines
have been optimized for several technical applications,
they could not be used for medical applications owing to
their toxicity [53]. The scaffolds made by electrospinning
exhibit better cellular attachment, growth and differentiation
compared with those made by other techniques. These
properties probably originate from the large specific
surface area (i.e. surface area-to-volume ratio) provided
by a low-dimension fibrous structure, which facilitates
cell adhesivity to the electrospun fibers. Thus, in this
review article, we present the advantages of electrospinning
techniques and the scaffolds made from electrospun fibers
for TE applications. In this context, the connective TE
is the most promising field of research that provides a
potential clinical application to repair or regenerate injured
tissues. After the pioneering discovery of mesenchymal stem
cells (MSCs) by Friedenstein in the late 1970s [71], the
number of studies on bone and cartilage TE has grown
dramatically. Recently, bone-marrow-derived mesenchymal
stem cells (BM-MSCs) [72], umbilical cord blood-derived
mesenchymal stem cells (UCB-MSCs) [73], muscle-derived
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Figure 4. Different fiber arrangements in 3D scaffolds: (a) 0◦/90◦, (b) 0◦/60◦/120◦, (c) randomly oriented and (d) converging oriented
fibers. (e) Surface morphology of a regenerative scaffold.
stem cells (MDSCs) [74], embryonic stem cells (ESCs) [75],
adipose tissue-derived stem cells (ADSCs) [76] and dental
pulp stem cells (DPSCs) [77] have been extensively explored
in the field of connective TE owing to their distinct biological
capability to differentiate into osteogenic lineages [78].
3. Progress in bone scaffold development
More than 50 polymers were employed during the last
decade [24, 67, 68, 79] for scaffolding hard tissues,
more specifically bone tissue. However, no single-phase
polymer has shown the desired properties for bone TE
applications. Regeneration or reconstruction of bone tissue
involves three key factors namely, osteogenic progenitor
cells, osteoinductive growth factors, and osteoconductive
matrices [53]. Also, the selection of both materials and
fabrication techniques is crucial for an ideal scaffold. The
bone is such a structural composite material that it has a
very high specific strength (i.e. strength-to-weight ratio). The
tubular shape of bone can resist a bending force that causes
compression on one side and tension on the reverse side.
3.1. Strategy for selection of scaffold materials to improve
mechanical properties
Selection of materials for hard TE scaffolds depends on the
properties required for real applications. For bone tissue,
one of the major criteria is high strength and toughness.
The ultimate strength should be such that the scaffold does
not fracture before the complete growth of new tissues. The
essential mechanical properties of different materials for bone
TE scaffolds can be found in [68, 79]. The mechanical
properties of polymers can be improved by several methods
as discussed below.
3.1.1. Crystallinity. The mechanical properties of most
polymers depend on crystallinity, which generally increases
with the number of polar groups in the polymer chain.
However, an opposite tendency is observed for some
functionalized polymers and attributed to the asymmetric (i.e.
atactic or syndiotactic) stereographic position of the pendant
functional groups. This asymmetric structure helps to increase
the mobility of polymer chains, and therefore reduces the
crystallinity and mechanical properties of the polymer. A
more detailed explanation of this new finding is given in the
original report [80].
3.1.2. Copolymerization. Copolymerization is one of the
best techniques to increase the mechanical properties
of polymers. The mechanical properties of copolymers
can be improved by increasing the size of crystalline
domains [81], molecular bond strength [82], tacticity or
stereographic position [80], hydrophilicity [83] and so on. In
copolymerization, the molecular bond strength is increased by
grafting between different polymers, which in turn increases
the mechanical properties of bulk copolymer. Polymerization
may also affect the mechanical properties. For example, the
mechanical strength increases with time and temperature
of corona discharge polymerization, whereas ultraviolet
irradiation decreases the mechanical strength of polymer
materials [82].
3.1.3. Hydrophilicity. The mechanical and biological
properties of polymeric materials can be improved
6
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Scaffold material Application Technique Technique
Polymers
Porous biodegradable poly Tissue regeneration or reconstruction Emulsion freeze-drying [22] Yes
(dl-lactide-co-glycolide)
(PLGA) copolymers
Porous poly(l-lactic acid) (PLLA), Skin tissue scaffolding using ROS Freeze-extraction and freeze- Yes
PLGA, chitosan and alginate 17/2.8 osteoblast-like cells (rat gelation [54]
osteosarcoma)
Porous polyethylene glycol Scaffold for cartilage Compression molding and Yes
terephthalate/polybutylene TE applications using chondrocytes particle leaching [55]
terephthalate (PEGT/PBT)
Poly(ethylene oxide) and Scaffolds for soft tissues in terms of Stereolithography [50] Yes
poly(ethyleneglycol)dimethacrylate elasticity
photopolymerizable hydrogels
Polycaprolactone Bone scaffolds for bone morphogenetic Selective laser sintering [56] Yes
protein-7 (BMP-7)-transduced
fibroblasts
Chitosan Electrobiological Electrochemical process [57] Yes
DNA ‘square-U’-based structure Single-strand DNA origami Polymerase chain reaction [9] Yes
for biological nanoelectronics
Biodegradable polyurethane (PU) Skin tissue scaffolding using human Melt electrospinning [58] –
fetal foreskin fibroblast cells
Ceramics
Porous hydroxyapatite (HAp) Load-bearing bone scaffold Combination of gel casting and No
polymer sponge [59]
Biomorphic silicon carbide Bone implants, e.g. load-bearing Biotemplating [60] No
ceramics, uncoated or coated prostheses using MG-63 human
with bioactive glass osteoblast-like cells
High-strength HAp Load-bearing bone scaffold Solid-state reaction [5] No
Bioactive, degradable and Bone tissue scaffold using Sol–gel [61] No
cytocompatible bredigite osteoblast-like cells
(Ca7MgSi4O16)
Biomorphic HAp Bone tissue scaffold and implant Combination of novel No
biotemplating and sol–gel
methods [62]
Nanostructure HAp Low-strength TE including drug Gel casting [63] No
delivery and cell loading
Composites
Polyvinyl alcohol (PVA)/HAp Scaffolds for craniofacial and Selective laser sintering [64] Yes
joint defects
PLGA/HAp composite and DNA and PLGA/HAp composite Electrospinning [65] –
PLGA-dichloromethane-HAp- scaffold for bone TE
DNA/nanoparticles
Chitosan/calcium phosphates TE Membrane diffusion followed by Yes
effective freeze-drying [66]
Polyether etherketone Human trabecular bone TE Unconfined uniaxial compression Yes
(PEEK)/HAp scaffold [67, 68]
Thermoplastic PU/ collagen TE scaffold using pig iliac Coaxial electrospinning [69] –
endothelial cell (PIEC)
proliferation
Polycaprolactone with 0–50 wt% Scaffold for bone TE Electrospinning [70] –
ceramic (20 wt% HAp/ 80 wt%
β-tricalcium)
by increasing their hydrophilicity [84]. Normally, their
mechanical properties vary for the dry and hydrated states,
whist the last condition is mostly employed in TE scaffolds or
implant devices [84]. In 2009, Li et al conducted a tensile test
on poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate]
(PHBV) and its blends with poly[(R)-3-hydroxybutyrate]-
alt-poly(ethylene oxide) (HE) after immersion in phosphate
buffer solution for 24 h at 37 ◦C. Their results showed that the
strain and hydrophilicity of the PHBV/HE blends increased
gradually with the HE content, and the ultimate tensile
strength (UTS) also increased (by 110%) up to a certain
weight percentage, i.e. 5 wt% HE. Conversely, above 5 wt%
HE, the PHBV/HE hybrids had higher elastic strain and
hydrophilicity, but lower UTS. The results indicate that HE
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improves the hydrophilicity of PHBV/HE polymers through
surface modification, and the hydrophilicity further increases
the mechanical properties by increasing the crosslinking
between the poly[(R)-3-hydroxybutyrate] (PHB) segments
of HE and PHBV matrix up to a certain level (i.e. 5 wt%
HE for this PHBV/HE system). Above a critical level, the
water absorption increases rapidly, and this deteriorates
the mechanical strength [84]. Lu et al [85] reported that
the tensile and tear strengths of addition silicone, which
is generally hydrophobic and is used as an impression
material, can be improved by making it hydrophilic after
the addition of surfactants. It has also been found that the
moderately hydrophilic polymers support the attachment of
a high fraction of fibroblast cells [83]. Moreover, the cell
adhesion via adsorbed protein can be improved by surfaces
with intermediate wettability. On the other hand, hydrophobic
polymers such as polytetrafluoroethylene polypropylene
and polyethyleneterapthalate, polystyrene provide a limited
support for cell attachment. The poor cell attachment to
nonpolar polymers (e.g. polystyrene) is possibly related to
the lower degree of crystallinity in amorphous materials or
hydrophobic polymers [83]. The different crystallinities of
hydrophobic polymers further alter the mechanical properties.
However, a technical problem associated with hydrophilic
polymers, which is frequently faced when changing the
medium during in vitro cell culture experiments, is that
smaller hydrophilic electrospun fibers are lifted off the bulk
scaffold owing to higher wetting in aqueous medium [40].
This problem can be solved by optimizing the hydrophilicity
of polymers using proper surface modifiers.
3.1.4. Surface treatment. A few recent studies have shown
that the mechanical properties of the bulk polymers or
fibrous polymers can be improved by several surface
treatment techniques [80, 86]. The polymer surface is
effectively modified with polar groups containing ester
(–COOR), ether (–O–), ketone (>CO), epoxy, carboxylic
acid (–COOH), hydroxyl (–OH), acetyl (–COCH3), amide
(–CONH2), amine (–NH2) or other moieties by a suitable
surface treatment. The treatment improves the surface
activity, polarity, hydrophilicity and mechanical properties
of the electrospun polymers. The resulting surface-modified
electrospun fiber may be advantageous for TE scaffolds used
in connective tissues, including bone, cartilage, ligament and
tendon reconstructions or replacements.
3.1.5. Composite fabrication or hybridization. Most of the
recent investigations on tissue scaffoldings follow this
technique because it is inexpensive and allows easy and
precise control of the physical, chemical and biological
properties. The organic part of bone tissue, such as protein,
gives tensile strength and the inorganic part, calcium and
phosphorus salts, provides compressive strength to the bone.
The inorganic part of the natural bone is mostly similar to
synthetic hydroxyapatite (HAp, [Ca5(PO4)3OH]) in structure
and chemical composition. The structure of bone is a highly
organized hierarchy of the inorganic (HAp) and organic
(e.g. Type-I collagen) phases [60], and in situ growth of
inorganic phosphate compounds such as nanohydroxyapatite
on the nanoparticles or nanofibers of an organic polymer may
enhance the interfacial bonding between inorganic ceramics
and organic polymers [60, 87, 88]. This innovative technique
also improves the cell attachment and cell proliferation on the
scaffold surfaces.
3.1.6. Solubility. Many materials with low solubility have
good mechanical properties, biocompatibility and low
immune response. However, their limited solubility (e.g. for
chitosan, polyether ether ketone) hinders electrospinning
[80, 89]. Their good mechanical properties originate from
the network structure and strong hydrogen bonding. The
mechanical properties of electrospun composite scaffolds
also depend on the solubility of second-phase materials
used with the polymer matrix in the body plasma or
simulated body fluids. If the materials start to biodegrade or
dissolve during in vivo use, the mechanical properties of the
scaffold can deteriorate in an uncontrollable manner. This
is often observed in composites of polymers and calcium
phosphates. Several types of calcium phosphates have been
used in various biomedical fields, and their stability in
water under physiological conditions (pH 7.4, at 37 ◦C)
increases in the following sequence: monocalcium phosphate
[MCP, Ca(H2PO4)2 · H2O], tetracalcium phosphate [TTCP,
Ca4P2O9], α-tricalcium phosphate [α-TCP, α-Ca3(PO4)2],
dicalcium phosphate dihydrate [DCPD, CaHPO4 · 2H2O],
dicalcium phosphate [DCP, CaHPO4], octacalcium phosphate
[OCP, Ca8(HPO4)2(PO4)4 · 5H2O], β-tricalcium phosphate
[β-TCP, β-Ca3(PO4)2], calcium-deficient hydroxyapatite
[CDHAp, Ca9(HPO4)(PO4)5OH], HAp [90]. Therefore,
depending on the mode of application, different ceramics
and biopolymers should be combined in composite or hybrid
scaffolds.
3.2. Selection of electrospinning technique
Synthetic polymer-based electrospun fibers offer adjustable
mechanical properties and surface functionalization via
biomolecular coatings or chemical conjugation of specific
signaling molecules. The vital properties of electrospun fibers
that can be tuned via electrospinning are nanofiber diameter,
surface morphology, mechanical properties, porosity and
pore-size distribution [91]. The basic principle of the
electrospinning process is that an electrical voltage, which is
sufficient to overcome the surface tension of the polymeric
solution, causes the polymer droplets to elongate and eject
as a fine fiber [70]. The electrospun fibers are used to
form non-woven mats that are assembled into scaffolds.
In this process, better fibers are produced from polymers
with higher molecular weights. One of the major advantages
of electrospun fibers is that they have better molecular
binding, which in turn improves their mechanical properties.
Electrospinning can be performed in various modes including
solution, melt and coaxial electrospinning. In solution
electrospinning, the polymer is dissolved in a suitable solvent,
whereas in melt electrospinning, the polymer is directly
electrospun from the melt. The former method produces
8
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Figure 5. Schematic of electrospun fibers with (a) desired properties and required process parameters in aligned morphology and (b) high
bead density and randomly oriented (undesired) morphology.
a wide range of fiber diameters, which are limited to
microns in the latter technique. Melt electrospinning does
not require toxic organic solvents and is ideal for scaled-up
processes. However, it requires elevated temperatures for the
melt, whereas stable solutions can be electrospun at room
temperature. The third variety, coaxial electrospinning, is
advantageous in the sense that it produces hollow fibers that
can transport nutrients and waste in and out of scaffolds as
elsewhere [2]. The morphology or microstructure of such
scaffolds is similar to the bone architecture. The crucial
electrospinning parameters that can alter the fiber properties
are applied voltage, spinneret flow rate, target speed [40],
collection distance, target properties, polymer molecular
weight and polymer solution properties such as solvent type,
concentration, viscosity, conductivity and surface tension
[91, 92]. In general, the fiber diameter decreases and the
fiber quality increases as the voltage is increased; the fiber
diameter also decreases at lower flow rates [40]. Fiber
alignment in a particular direction can be improved by
increasing the speed of the target in an electrospinning system.
The electrostatic forces exerted by interfiber interactions
mainly control the motion of fibers ejected from the polymer
jet during electrospinning; these forces depend on the
external field, collector type and charges. As these forces
have no preferential direction, randomly oriented nanofibers
are formed on a stationary target. However, more aligned
and parallel fibers are deposited on a rotating target or
a drum [93]. The bead density in fibers decreases with
increasing polymer concentration or viscosity [39], and the
uniformity of bead-free fibers can be improved by increasing
the ionic conductivity of the source polymer. Conducting
polymer solutions carry more electric charge and generate
stronger repulsive forces on the polymer jet. Therefore,
polymer solutions containing ionic salts form more uniform
fibers than pure polymers [94]. The properties and process
parameters required for aligned fibers are summarized in
figure 5.
Figure 6. (a) Optimum interfiber space (supporting cell growth)
and (b) large interfiber space (hindering cell growth).
3.2.1. Electrospun scaffolds in premade porous scaffolding
approach. The research on electrospun scaffolds has
recently been invigorated by introducing the premade porous
scaffolding approach for skeletal system or connective tissues,
including bone repair and/or regeneration. The cell growth
property depends on the morphology and fiber orientations
in scaffolds [57]. The space between fibers and the position
of the fibers in a scaffold should allow the easy growth of
cells [95, 96] as illustrated in figure 6.
Recently, Dalton et al have obtained a peculiar result
(figure 7) on coiled electrospun fibers [40]. Fibroblast cells
have been found to grow nicely inside and outside coil
or ring-like fibers (figures 7(c) and (d)), whereas the cells
could not attach properly to randomly oriented, entangled
fibers [40] (figure 7(e)). This behavior can be attributed to
the amorphous and hydrophobic nature of highly entangled
long-chain polymeric fibers. Therefore, better cell attachment
and tissue ingrowth are expected for scaffolds made of
coiled electrospun fibers compared with randomly oriented,
entangled fibers.
Besides in vitro attempts, many in vivo investigations
have been carried out to repair bone defects using TE
scaffolds made of various electrospun nanofibers. A schematic
of an ideal electrospinning technique (coaxial method)
for bone reconstruction is illustrated in figure 8(A). The
treatment of complicated fractures and large osseous defects
is a challenging problem for orthopedic surgeons. In 2011,
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Figure 7. Redrawn fluorescent images of electrospun fibers (a) with cells grown inside and outside the coil or ring-type fibers and (b) cells
outside the randomly oriented entangled structure (adopted from [40] with permission). Schematic of cell attachment to electrospun fibers:
(c) cell inside the coil, (d) cell outside the coil and (e) cells outside randomly oriented, long entangled fibers.
Figure 8. (A) Schematic of a coaxial electrospinning setup. (B) Scanning electron microscopy image of electrospun nanofiber mesh
illustrating the smooth and bead-free fibers with nanosized diameters; the inset shows the layers of fibers in a scaffold. (C) Hollow tubular
implant made from nanofiber meshes without and with perforations. (D) In vivo application of the nanofiber mesh tubes as implants placed
around an 8 mm segmental femoral rat bone defect (in some groups, alginate hydrogel, with or without rhBMP-2, is injected inside the
hollow tube). (E) Defect after implantation of a perforated mesh tube; the alginate inside the tube can be seen through the perforations. (F)
After 1 week, the mesh tube was cut open, and the alginate was still present inside the defect with hematoma at the bone ends. (G) In vitro
alginate release kinetics: sustained release of the rhBMP-2 was observed during the first week (images B-G are taken from [97] with
permission).
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Kolambkar et al [97] made a formidable effort to introduce
electrospun nanofiber mesh tubes (effective pore size
<5µm, porosity 80–90%) as a guide for rat bone regeneration
in a segmental bone defect. The nanofibers were made of
polycaprolactone and had diameters ranging from 51 to
974 nm, with 82% of the values lying between 50 and 150 nm.
The nanofiber mesh combined with peptide-modified alginate
hydrogel (i.e., recombinant bone morphogenetic protein-2
(rhBMP-2)) was injected inside the tube for sustaining the
growth factor release. A typical in vivo use of the perforated
scaffold or mesh made of electrospun nanofibers, combined
with growth factor (rhBMP-2), for bone defects is illustrated
in figures 8(B)–(F). Figure 8(G) shows the performance
of this model up to 21 days, revealing that most alginate
release (98.6%) took place within the first 7 days. This novel
electrospun hybrid system allowed complete bony bridging of
challenging segmental bone defects in rat.
3.2.2. Electrospun scaffolds in decellularized ECM approach.
Recently, bone regeneration has been attempted with natural
materials fabricated into scaffolds, such as demineralized
bone as a nanoscale-bone-matrix (NBM) powder, for
improving the mechanical and osteoinductive properties [98].
Interactions between cells and ECM are very important
for isolating cells and modulating or redirecting their
functions [99]. The major advantages of electrospun fibers
in the engineered scaffolds are that they provide micro-
to nanoscale topography and high porosity similar to
the natural ECM [92]. The high surface-to-volume ratio
of nanoscale electrospun scaffolds can enhance the cell
attachment, drug loading, and mass transfer properties [100].
The porosities resulting from electrospinning help transport
nutrients and waste within the decellularized ECM approach.
On the other hand, the nonwoven fibrous mats consisting
of nanofibers provide a high surface area to interact with
and attach to cells [101]. In this context, electrospun fibers
of poly(l-lactide) (PLA) with 20% NBM have shown a
higher Young’s modulus than pure PLA. These electrospun
NBM/PLA composite nanofibers exhibit the properties
similar to those of the native collagen-rich mineralized bone
matrix and therefore can be used as a temporary substrate for
facilitating the isolation and mineralization of bone-forming
cells [1].
3.2.3. Electrospun scaffolds in cell-sheets with secreted ECM
approach. The uniform aligned electrospun collagen fibers
may be an ideal candidate to mimic complex structures in
regular connective tissues such as tendons, ligaments and
bones. The aligned electrospun fibers will also allow the
fibroblasts and collagens to organize in the same orientation.
Recently, the cell-sheet approach has been exploited to
establish a novel method of tissue reconstruction in bone
tissue regenerative medicine [103]. In this approach, there
is no need for the scaffold to construct a cell-dense tissue,
and it can be transplanted to various damaged tissues without
any other treatment (e.g. suturing). The cell sheets can also
be controlled with a polymer-coated plunger for transferring
and stacking onto other cell sheets. Importantly, the stacking
method allows two cell sheets to contact each other physically,
as well as to communicate biologically. The control of
cell alignment may be a key factor in the next-generation
cell-sheet-based tissue reconstruction technology [103].
3.2.4. Electrospun scaffolds in cell-encapsulated self-
assembled hydrogel approach. Several hydrogel materials
have been scaffolded for connective TE applications using the
cell-encapsulated self-assembled hydrogel approach [104].
The porous hydrogel scaffolds can be used for microcarrier
suspension culture of cells and for injection of the
cell/microsphere constructs into a tissue defect. The injected
porous scaffolds permit infiltration of cells and ingrowth
of tissue from the host, and facilitate the regeneration
process [105]. A variety of electrospun hydrogels fibers
have also been developed for advanced applications [106],
and different composites or hybrids of hydrogel materials
have been studied for tissue engineering applications [107].
Self-assembling biomolecules (e.g. peptides) have been used
for in vitro 3D culture of cells, in vivo tissue regeneration or
repair of bones and optical nerves, as well as drug delivery
and other applications [108]. Many important properties (e.g.
swelling, mechanical properties, diffusion and degradation)
of hydrogel in scaffolds can be tuned by controlling the
molecular structure of the hydrogels. The molecular structure
depends on both degree and density of crosslinking—the
mechanical properties of the hydrogel improve as the
crosslinking density increases [36]. However, a higher
crosslinking density results in inferior swelling properties and
mesh sizes, i.e. the distance between the crosslinks, which
influences diffusion through the hydrogel. Thus, while the
mechanical strength, which is desirable for in situ placement
in articular cartilage, is improved, the swelling and diffusion
properties are sacrificed [36]. More research is needed on
the cell-encapsulated self-assembled hydrogel approach to
develop new strategies in bone tissue regeneration [95, 96].
4. Concluding remarks
Selection of the raw material for bone TE applications
is crucial for the development of an ideal scaffold—the
materials and fabrication technique are to be chosen in
accordance with the specific tissue application. Selection of
the fabrication technique is also important for developing
a proper morphology in the electrospun scaffold. Melt
electrospinning can produce finer fibers as compared with
other methods. However, hollow tubular fibers produced
by coaxial electrospinning are preferred for the transport
of nutrients and waste in and out of the bone scaffold.
All the physicochemical properties including porosity, pore
geometry, surface roughness, surface chemistry and biological
and mechanical properties should be considered when
designing a scaffold. Therefore, a combination of solid and
hollow fibers may be optimal for bone applications. After
developing a scaffold, it is essential to evaluate its safety for
long-term implantations. Therefore, more in vitro experiments
on electrospun scaffolds are needed for developing a novel
strategy of bone tissue repair and/or regeneration before
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actual in vivo implementations [95, 96]. In this context,
the development of new TE scaffolds that could assist in
the regeneration of large bone defects must be considered.
Additionally, the scaffolds should promote not only the
biomineralization, but also the maintenance of biological and
mechanical properties for tissue regeneration.
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